Invesco LLC (Illinois)’s Vertex Pharmaceuticals VRTX Stock Holding History

Invesco LLC (Illinois)’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$542K	Hold	1,091	–	–	0.17%	95
2026 Q1	$487K	Hold	1,091	–	–	0.17%	93
2025 Q4	$495K	Hold	1,091	–	–	0.17%	90
2025 Q3	$427K	Hold	1,091	–	–	0.14%	98
2025 Q2	$486K	Hold	1,091	–	–	0.18%	92
2025 Q1	$529K	Hold	1,091	–	–	0.22%	86
2024 Q4	$439K	Hold	1,091	–	–	0.18%	101
2024 Q3	$507K	Hold	1,091	–	–	0.2%	91
2024 Q2	$511K	Hold	1,091	–	–	0.21%	91
2024 Q1	$456K	Hold	1,091	–	–	0.19%	100
2023 Q4	$444K	Hold	1,091	–	–	0.21%	93
2023 Q3	$379K	Hold	1,091	–	–	0.19%	101
2023 Q2	$384K	Buy	+1,091	New	+$368K	0.19%	109

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Invesco LLC (Illinois)'s VRTX Position: Q2 2026 in Review

Invesco LLC (Illinois) held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 1,091 shares worth $542K. The position accounts for 0.17% of the portfolio, ranked #95.

Invesco LLC (Illinois) first reported a position in VRTX in Q2 2023 and has held it in 13 quarters since. 750 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Invesco LLC (Illinois) held 1,091 shares of Vertex Pharmaceuticals worth $542K as of Q2 2026.
Invesco LLC (Illinois) left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.17% of Invesco LLC (Illinois)'s portfolio in Q2 2026, its #95 holding.
Invesco LLC (Illinois) first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
750 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Invesco LLC (Illinois)'s 13F filing for Q2 2026, filed 21 Jul 2026.